| Primary |
| Nephrogenic Anaemia |
50.0% |
| Product Used For Unknown Indication |
40.0% |
| Anaemia Of Chronic Disease |
10.0% |
|
| Renal Failure Chronic |
22.2% |
| Ascites |
11.1% |
| Drug Ineffective |
11.1% |
| Melaena |
11.1% |
| Myocardial Infarction |
11.1% |
| Road Traffic Accident |
11.1% |
| Vascular Graft Complication |
11.1% |
| Ventricular Tachycardia |
11.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.6% |
| Breast Cancer |
11.0% |
| Anaemia |
7.7% |
| Breast Cancer Metastatic |
6.2% |
| Multiple Myeloma |
5.8% |
| Product Used For Unknown Indication |
5.6% |
| Hepatitis C |
5.2% |
| Hypertension |
5.2% |
| Anaemia Of Chronic Disease |
4.8% |
| Nephrogenic Anaemia |
3.7% |
| Prophylaxis |
3.1% |
| Chronic Hepatitis C |
2.3% |
| Dialysis |
1.7% |
| Refractory Anaemia With An Excess Of Blasts |
1.7% |
| Cerebral Malaria |
1.2% |
| Haemoglobin Decreased |
1.2% |
| Sclerosing Encapsulating Peritonitis |
1.2% |
| Mantle Cell Lymphoma |
1.0% |
| Renal Failure Chronic |
1.0% |
| Eczema |
0.8% |
|
| Acute Myeloid Leukaemia |
9.6% |
| Cardiovascular Disorder |
8.5% |
| Tooth Abscess |
8.5% |
| Bartholin's Abscess |
6.4% |
| Facial Palsy |
6.4% |
| Haemoglobin Decreased |
6.4% |
| General Physical Health Deterioration |
5.3% |
| Pyrexia |
5.3% |
| Adverse Event |
4.3% |
| Aplastic Anaemia |
4.3% |
| Chest Discomfort |
4.3% |
| Death |
4.3% |
| Septic Shock |
4.3% |
| Anti-erythropoietin Antibody |
3.2% |
| Aplasia Pure Red Cell |
3.2% |
| B-cell Lymphoma |
3.2% |
| Cholecystitis |
3.2% |
| Completed Suicide |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Idiopathic Pulmonary Fibrosis |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
34.9% |
| Product Used For Unknown Indication |
17.0% |
| Hypertension |
6.2% |
| Anaemia |
5.4% |
| Renal Failure Chronic |
4.6% |
| Hyperparathyroidism Secondary |
4.2% |
| Peritoneal Dialysis |
3.3% |
| Breast Cancer |
3.1% |
| Prophylaxis |
3.1% |
| Coronary Artery Disease |
2.6% |
| Renal Failure |
2.1% |
| Hepatitis C |
2.0% |
| Hyperphosphataemia |
2.0% |
| Multiple Myeloma |
1.9% |
| Pain |
1.5% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types |
1.3% |
| Hiv Infection |
1.3% |
| Pancytopenia |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Hyperlipidaemia |
1.1% |
|
| Pyrexia |
14.3% |
| Sclerosing Encapsulating Peritonitis |
10.9% |
| Vomiting |
10.9% |
| Acute Myeloid Leukaemia |
5.4% |
| Rhabdomyolysis |
5.4% |
| General Physical Health Deterioration |
4.8% |
| Renal Failure |
4.8% |
| Sepsis |
4.8% |
| Myocardial Infarction |
4.1% |
| Peritonitis |
4.1% |
| Nausea |
3.4% |
| Pericardial Effusion |
3.4% |
| Pneumonia |
3.4% |
| Sudden Death |
3.4% |
| Urinary Retention |
3.4% |
| Angina Pectoris |
2.7% |
| Aplastic Anaemia |
2.7% |
| Capillary Leak Syndrome |
2.7% |
| Constipation |
2.7% |
| Loss Of Consciousness |
2.7% |
|
